RB

Ruchika Bansal

Active Director Director DIN 02509691
DIN 02509691 First appointment Jan 2006 Primary industry Real Estate and Construction
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Jan 2006
Shareholding value •••• Premium profile

About Ruchika Bansal

Data last updated:

Ruchika Bansal is a Director at Jain Medical Center Private Limited (since 2012), Director at Devansh Real Estate Developers Private Limited (since 2006) and Designated Partner at Lotus D3m Developers Llp (since 2024), and holds 1 more current directorship. The companies operate in Real Estate and Construction and Real Estate. The 2 current companies with reported revenue have a combined latest revenue of ₹32.2 Lakh; the largest is Jain Medical Center Private Limited at ₹30.4 Lakh (FY 2025). Earlier, Ruchika Bansal was a Director at Kapsons Developers Private Limited (2016–2019) and Director at Devansh Realtors Private Limited (2007–2016).

DIN 02509691
Primary Designation Director
Industry Real Estate and Construction
First Appointment 27 Jan 2006
Oldest Company Age 34 yrs
Largest company Jain Medical Center Private Limited · ₹30.4 Lakh (FY 2025)
Combined revenue ₹32.2 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jain Medical Center Private Limited U74899DL1992PTC047489
Director24 Jul 20121992₹30.4 Lakh (FY 2025)Active
Director27 Jan 20062006₹1.8 Lakh (FY 2025)Active
Designated Partner19 Jun 20242024Active
Lotus Proptech Private Limited U70109HR2014PTC053536
Director01 Oct 20142014Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kapsons Developers Private Limited U45200DL2008PTC174746
Director07 Mar 20162008Strike Off
Devansh Realtors Private Limited U45200DL2007PTC160076
Director05 Mar 20072007₹1.02 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Devansh Real Estate Developers Private Limited
Lotus Proptech Private Limited
Jain Medical Center Private Limited
Lotus D3m Developers Llp
Premium access

Shareholding and investment profile for Ruchika Bansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ruchika Bansal

Ruchika Bansal currently holds 4 directorships: Jain Medical Center Private Limited (Director, since 24 Jul 2012, revenue ₹30.4 Lakh (FY 2025)); Devansh Real Estate Developers Private Limited (Director, since 27 Jan 2006, revenue ₹1.8 Lakh (FY 2025)); Lotus D3m Developers Llp (Designated Partner, since 19 Jun 2024); Lotus Proptech Private Limited (Director, since 01 Oct 2014).

Ruchika Bansal was first appointed on 27 Jan 2006 as Director at Devansh Real Estate Developers Private Limited. The most recent appointment on record is 19 Jun 2024 at Lotus D3m Developers Llp.

The 2 current companies of Ruchika Bansal that report revenue have a combined latest revenue of ₹32.2 Lakh: Jain Medical Center Private Limited ₹30.4 Lakh (FY 2025); Devansh Real Estate Developers Private Limited ₹1.8 Lakh (FY 2025).

Ruchika Bansal held 2 earlier board appointments: Kapsons Developers Private Limited (Director, 07 Mar 2016 to 27 Feb 2019); Devansh Realtors Private Limited (Director, 05 Mar 2007 to 25 Mar 2016).

The current boards of Ruchika Bansal's companies include Devansh Bansal (Jain Medical Center Private Limited), Sheela Devi (Jain Medical Center Private Limited), Achal Rohatgi (Lotus D3m Developers Llp), Manish Bansal (Lotus Proptech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available